MARKET

PBLA

PBLA

Panbela Therapeutics Inc
EXMKT
0.011
NaN%
Closed 09:30 02/13 EST
OPEN
--
PREV CLOSE
0.011
HIGH
--
LOW
--
VOLUME
--
TURNOVER
--
52 WEEK HIGH
520.20
52 WEEK LOW
0.0002
MARKET CAP
53.89K
P/E (TTM)
-0.0003
1D
5D
1M
3M
1Y
5Y
1D
Weekly Report: what happened at PBLA last week (0202-0206)?
Weekly Report · 4d ago
Weekly Report: what happened at PBLA last week (0126-0130)?
Weekly Report · 02/02 10:23
Weekly Report: what happened at PBLA last week (0119-0123)?
Weekly Report · 01/26 10:23
Weekly Report: what happened at PBLA last week (0112-0116)?
Weekly Report · 01/19 10:29
Weekly Report: what happened at PBLA last week (0105-0109)?
Weekly Report · 01/12 10:28
Weekly Report: what happened at PBLA last week (1229-0102)?
Weekly Report · 01/05 10:22
Weekly Report: what happened at PBLA last week (1222-1226)?
Weekly Report · 12/29/2025 10:22
Weekly Report: what happened at PBLA last week (1215-1219)?
Weekly Report · 12/22/2025 10:22
More
About PBLA
Panbela Therapeutics, Inc. is a clinical-stage biopharmaceutical company. The Company is developing disruptive therapeutics for the treatment of patients with urgent unmet medical needs. The Company’s lead candidates are ivospemin (SBP-101), for which it has licensed the worldwide rights from the University of Florida Research Foundation, Inc., Flynpovi, a combination of eflornithine (CPP-1X) and sulindac and eflornithine (CPP-1X), alone in tablet or sachet form. It has licensed rights from the Arizona Board of Regents of the University of Arizona to commercialize Flynpovi. Additionally, eflornithine is being evaluated with high dose testosterone and enzalutamide in metastatic castration-resistant prostate cancer in a phase II trial. The Company is engaged in over two sponsored research agreements to evaluate the polyamines individually and combined for various diseases.

Webull offers Panbela Therapeutics Inc stock information, including EXMKT: PBLA real-time market quotes, financial reports, professional analyst ratings, in-depth charts, corporate actions, PBLA stock news, and many more online research tools to help you make informed decisions. Trade stocks for 0 commission and 0 contract fees on the web version for easy and convenient access, or download the Webull app and trade on the go.

You can practice and explore trading PBLA stock methods without spending real money on the virtual paper trading platform.